Showing 1 - 10 of 18
External referencing (ER) imposes a price cap for pharmaceuticals, based on prices of identical or comparable products …
Persistent link: https://www.econbiz.de/10010707663
pharmaceuticals in developing countries and should increase trade. The industry argues that other factors are necessary for poor … the United States’ trade of pharmaceuticals? A gravity model using panel data from 1993 to 2007 shows that foreign patent … protection is not a strong determinant of the United States imports and exports of pharmaceuticals. An OLS estimation, a Tobit …
Persistent link: https://www.econbiz.de/10010708922
Persistent link: https://www.econbiz.de/10010707095
Persistent link: https://www.econbiz.de/10010861406
Persistent link: https://www.econbiz.de/10010861586
Hospital heterogeneity is a major issue in defining a reimbursement system. If hospitals are heterogeneous, it is difficult to distinguish which part of the differences in costs is due to cost containment efforts and which part cannot be reduced, because it is due to other unobserved sources of...
Persistent link: https://www.econbiz.de/10010706753
Persistent link: https://www.econbiz.de/10010706996
Persistent link: https://www.econbiz.de/10010707566
Persistent link: https://www.econbiz.de/10010707914
This paper studies the relationship between the diffusion of innovative procedures for the treatment of heart attack and distributions of the cost and length of hospital stays. Using a sample of 5,681 stays observed in French public hospitals, we use microsimulation techniques to highlight...
Persistent link: https://www.econbiz.de/10010708126